Xtant Medical Holdings (XTNT) Depreciation & Amortization (CF) (2010 - 2025)

Xtant Medical Holdings (XTNT) has reported Depreciation & Amortization (CF) for 16 consecutive years, with $1.2 million the latest figure, recorded in Q3 2025.

• On a quarterly basis, Depreciation & Amortization (CF) rose 8.2% year-over-year to $1.2 million in Q3 2025; TTM through Dec 2025 was $3.4 million, a 19.41% decrease from a year earlier, with the FY2024 full-year figure at $4.2 million, up 33.08% from the prior year.
• Depreciation & Amortization (CF) was $1.2 million for Q3 2025 at Xtant Medical Holdings, down from $1.2 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $1.2 million in Q2 2025 and troughed at $281000.0 in Q1 2022.
• A 5-year average of $706631.6 and a median of $803000.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
• Across the five-year window, Depreciation & Amortization (CF) sank 45.26% in 2021 and jumped 216.82% in 2023, its largest moves.
• Over 5 years, Depreciation & Amortization (CF) stood at $291000.0 in 2021, then climbed by 10.31% to $321000.0 in 2022, then jumped by 216.82% to $1.0 million in 2023, then rose by 12.88% to $1.1 million in 2024, then rose by 1.13% to $1.2 million in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $1.2 million (Q3 2025), $1.2 million (Q2 2025), and $1.1 million (Q1 2025), per Business Quant data.